Relationship between Human T Lymphotropic Virus (HTLV) Type 1/2 Viral Burden and Clinical and Treatment Parameters among Patients with HIV Type 1 and HTLV-1/2 Coinfection
Open Access
- 1 May 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (9) , 1229-1234
Abstract
Background. Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are frequent copathogens among individuals infected with human immunodeficiency virus type 1 (HIV-1). The long-term effects of coinfection are unknown, and little information exists regarding how levels of HTLV-1/2 viral burden are affected by antiretroviral medications. Methods. Factors associated with HTLV-1/2 viral burden were examined in patients with HIV–HTLV-1/2 coinfection. A total of 72 subjects were evaluated. The variables analyzed included HTLV-1/2 proviral load, HTLV-1/2 tax/rex mRNA expression, HIV load, HTLV-1/2 viral antigen detection in peripheral blood mononuclear cell (PBMC) cultures, T cell subsets, demographic variables (age, race, sex, and reported use of injection drugs), and administration of highly active antiretroviral therapy. Results. An HTLV-1/2 proviral DNA copy number >20,000 copies/106 PBMCs was significantly associated with the following variables: (1) a positive HTLV-1 Western blot test result, (2) a positive HTLV-1/2 PBMC culture result, (3) a positive tax/rex mRNA result, (4) an HIV load Conclusions. HTLV-1/2 proviral burden was significantly higher among patients with HIV–HTLV-1 coinfection than among patients with HIV–HTLV-2 coinfection. Highly active antiretroviral therapy may be of limited value in controlling virus expression of HTLV-1/2 in patients with HIV–HTLV-1/2 coinfection.Keywords
This publication has 12 references indexed in Scilit:
- HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: A marker of disease progressionJournal of the Neurological Sciences, 2005
- Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistryJournal of Clinical Virology, 2004
- Higher Human T Lymphotropic Virus (HTLV) Provirus Load Is Associated with HTLV‐I versus HTLV‐II, with HTLV‐II Subtype A versus B, and with Male Sex and a History of Blood TransfusionThe Journal of Infectious Diseases, 2004
- Clinical Outcomes and Disease Progression among Patients Coinfected with HIV and Human T Lymphotropic Virus Types 1 and 2Clinical Infectious Diseases, 2004
- Increased Human T-Lymphotropic Virus Type II Proviral Load Following Highly Active Retroviral Therapy in HIV-Coinfected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1–associated myelopathy (HAM/TSP)Blood, 2002
- In Vivo Fluctuation of HTLV-I and HTLV-II Proviral Load in Patients Receiving Antiretroviral DrugsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Real-Time Polymerase Chain Reaction Assay for Cell-Associated HTLV Type I DNA Viral LoadAIDS Research and Human Retroviruses, 2000
- HTLV-I and HTLV-II Virus Expression Increase With HIV-1 CoinfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Management of Coinfection with Human Immunodeficiency Virus and Human T-Cell Lymphotropic Virus Type IClinical Infectious Diseases, 1996